Physician profile
Robert Setton
NPI 1528301348
$2,200.32
in general payments reported to CMS, 2019-2025
11 companies · $613 in 2025
The $613 reported for 2025 was more than what 89% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.65 · 2021: $448 · 2022: $117 · 2023: $137 · 2024: $855 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $776.60 | 2020-2025 | Menopur |
| Baxter Healthcare | $278.72 | 2024 | Starling System |
| Emd Serono, INC. | $167.45 | 2022-2025 | |
| Hologic Sales and Service, LLC | $156.73 | 2024-2025 | Novasure, Omni Hysteroscope, Acessa Provu System |
| Agile Therapeutics, INC. | $125.11 | 2021 | |
| Axsome Therapeutics, INC. | $125.00 | 2025 | Auvelity |
| Myovant Sciences INC. | $125.00 | 2021 | |
| Evofem Biosciences, INC. | $123.57 | 2021 | |
| Organon LLC | $123.32 | 2025 | Jada System |
| Astellas Pharma US INC | $122.44 | 2024 | Veozah |
| Channel Medsystems, INC. | $76.38 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Setton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.